For years, Washington insiders from both parties spoke about lowering health care costs. Yet bills continued to rise, families struggled, and the system’s most powerful players received a free pass.
The Trump administration’s Department of Justice is now targeting one of the biggest drivers of high health care costs: anticompetitive contracting by dominant hospital systems.
Hospitals are businesses first and foremost — and like any business, they seek to maximize profits. Recent lawsuits against major hospital networks such as New York Presbyterian and Ohio Health signal that the era of unchecked hospital power is ending.
In city after city, hospital markets have consolidated until competition virtually disappears. When nearly all metropolitan areas feature highly concentrated systems, these entities leverage their dominance to lock in contracts that secure top-tier placement in insurance networks while blocking efforts to direct patients toward more affordable care options.
These so-called “anti-steering” provisions, though technical in nature, have a clear impact: higher prices and fewer choices for American families. When insurers and employers cannot design plans that reward lower-cost, high-quality providers, patients end up with more expensive options — whether they realize it or not. Workers pay higher premiums. Businesses face increased costs. Taxpayers ultimately bear the burden through government programs.
What makes the Trump administration’s actions significant is its willingness to challenge institutions long considered untouchable. Hospitals often enjoy a positive reputation in their communities and perform lifesaving work. However, that does not grant them the right to exploit market dominance to inflate prices.
By targeting these restrictive contracts, the administration is restoring competition — something missing from health care for too long. When plans can exclude overpriced systems or steer patients toward better-value options, the entire market operates as it should.
Evidence of this approach already exists: plans that avoid the most expensive hospital systems can significantly reduce costs without compromising care quality. Even modest steering efforts can yield meaningful savings. In a health care system as large as America’s, these savings translate into billions and real relief for families.
The corporate hospital industry has pushed back, claiming the lawsuits are misguided. But this is precisely what happens when entrenched interests face scrutiny — those who benefited from the status quo must now compete on an equal footing.
Instead of protecting powerful institutions, the Trump administration is standing up for patients, workers, and employers who have been bearing the cost for too long. This move underscores that markets function only when competition is protected — meaning rules must be enforced when violated.
For decades, Americans were told health care costs are too complex to fix. But sometimes the problem is simpler than experts admit: when a few dominant players write the rules, everyone else loses. President Trump and the Department of Justice are now rewriting that script.
Draining the swamp isn’t just about Washington politics. It’s about rooting out hidden arrangements and insider advantages that drive up costs across our economy — including in health care.
By challenging anticompetitive hospital contracting, the Trump administration proves no industry is above scrutiny. This action delivers a win for competition, affordability, and most importantly, the American people.
